Online inquiry

IVTScrip™ mRNA-Human APLP2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A))   (CAT#: GTTS-WK24912MR)

This product GTTS-WK24912MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 0 & 5-Methyl-CTP & Pseudo-UTP. It ecodes the APLP2 protein. This product can be used in Microglial cell-related researches.
Specifications
Product type mRNA
Modified bases 5-Methyl-CTP & Pseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_001142276.2
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 334
UniProt ID Q06481
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human APLP2, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) (GTTS-WK24912MR). Click the button above to contact us or submit your feedback about this product.
See other products
CAT Product Name Product Type CDs
GTTS-WK20004MR IVTScrip™ mRNA-Human ANKRD18A, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD18A
GTTS-WK21517MR IVTScrip™ mRNA-Human ANKRD31, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD31
GTTS-WK11061MR IVTScrip™ mRNA-Human ADORA2B, (Cap 1, Pseudo-UTP, 120 nt-poly(A)) mRNA ADORA2B
GTTS-WK25624MR IVTScrip™ mRNA-Human ARID3B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARID3B
GTTS-WK16139MR IVTScrip™ mRNA-Human ANKS4B, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ANKS4B
GTTS-WK8289MR IVTScrip™ mRNA-Human ADAM12, (Cap 0, 2-Thio-UTP, 120 nt-poly(A)) mRNA ADAM12
GTTS-WK14661MR IVTScrip™ mRNA-Human ANXA3, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ANXA3
GTTS-WK27412MR IVTScrip™ mRNA-Human ARHGEF19, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ARHGEF19
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →